Seresto

Quick links to important sections

Seresto

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Seresto

Quick Facts

Property Description
Active Ingredients Flumethrin, Imidacloprid
Form Polymer matrix collar
Pharmacological Class Ectoparasiticide (ATCvet: QP53AC55)
General Purpose Long-term external parasite control and prevention
Origin Synthetic

What is Seresto and its Pharmacological Class?

Seresto is defined as a specialized veterinary medicinal product classified as a combination ectoparasiticide, meaning its primary function is to eliminate and control external parasites, such as ticks and fleas, on companion animals. As a synthetic drug entity, it falls under the high-level pharmacological classification designated by the ATCvet code QP53AC55 (Flumethrin combinations). This product utilizes a synergistic blend of two highly effective chemical agents simultaneously to achieve broad-spectrum parasite control. This dual-action approach allows the product to tackle a wide range of external pests effectively, differentiating it from many single-ingredient treatments.


Composition and Unique Polymer Matrix Form

The Seresto product contains two primary active ingredients: Flumethrin, which is a synthetic pyrethroid, and Imidacloprid, a chloronicotinyl compound. This medication is administered via a unique dosage form, the collar, which serves as a polymer matrix system for continuous and topical drug delivery. The active components are embedded within this polymer material, ensuring their controlled, slow release from the collar's surface onto the pet's skin and coat, establishing and maintaining the necessary concentration for efficacy. This matrix delivery system ensures the continuous release of the active substances over an extended period, which is a key feature of the product.


General Purpose: Long-Term External Parasite Control

The general purpose of Seresto is to provide long-term protection and prevention against common external pests, such as fleas and ticks, typically lasting for up to eight months. The delivery mechanism ensures that a consistent, effective concentration of both active ingredients is present on the animal’s surface, functioning to eliminate or repel parasites rapidly upon contact. This sustained efficacy is the key benefit, particularly suitable for maintaining year-round parasite control for pets and preventing the establishment of new infestations.

Regulatory References

  1. National Institutes of Health

What side effects are possible with Seresto?

Possible Side Effects and Safety Information

The safety profile for the Seresto collar is based on data documented by governmental regulatory agencies. Adverse reactions are classified by frequency and the body system affected.

Frequency-Classified Adverse Reactions

The majority of reported reactions are categorized as Rare (occurring in 1 to 10 animals out of 10,000 treated) or Very Rare (occurring in fewer than 1 animal out of 10,000 treated).

System-Organ Class Rare Adverse Reactions (Examples)
Skin & Subcutaneous Tissue Erythema, Pruritus, Hair Loss (at application site)
Gastrointestinal Vomiting, Diarrhoea, Hypersalivation
Nervous System Ataxia, Convulsion, Tremor

Local application site signs, such as mild reddening or hair loss, are typically transient and often resolve within 1 to 2 weeks after initial application.

Serious Adverse Reactions and Safety Constraints

Regulatory documentation highlights the possibility of serious adverse reactions, including nervous system effects like convulsion (seizure) and severe hypersensitivity reactions. The physical design of the collar also carries a risk of mechanical strangulation or trauma, addressed by the safety-release mechanism.

Population-Specific Safety Limitations (Contraindications):

The product should not be used in the following circumstances, as defined in official regulatory documents:

  • In kittens less than 10 weeks of age or puppies less than 7 weeks of age.
  • In animals with known hypersensitivity to the active ingredients (Imidacloprid, Flumethrin).
  • In sick or convalescent animals.
  • During pregnancy or lactation, as safety has not been established.

If any serious reaction or persistent signs are observed, the collar should be removed immediately, as specified in the safety guidelines.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile indicates that pharmacological overdosage with the Seresto collar is unlikely and clinical signs are not expected under normal circumstances, a finding attributed to the device’s slow-release polymer system. The only explicitly documented pharmacological manifestation of overdose relates to the accidental oral ingestion of the collar itself, which may result in mild gastrointestinal symptoms, specifically loose stool.

When Urgent Medical Help Is Required

Regulatory authorities document key situations that necessitate immediate intervention. The label is required to mandate immediate collar removal and seeking emergency medical help if severe adverse signs, such as observed neurological symptoms (convulsions or ataxia), are seen. Furthermore, the distinct risk of mechanical strangulation or trauma has been documented by the U.S. Environmental Protection Agency (EPA) in relation to the device, constituting a life-threatening, non-pharmacological event that requires urgent intervention.

In cases of human exposure or poisoning, the official instruction requires contacting a doctor or Poisons Information Centre. Treatment for pharmacological effects is generally symptomatic and supportive, as the regulatory label does not document a specific antidote. Overdose safety studies included both adult dogs and 7-week-old puppies at multiples of the intended dose.

Therapeutic Uses of Seresto

What Seresto Treats: Main Uses and Benefits

The Seresto collar is generally used as a therapeutic option for long-term management and prevention of external parasite infestations, which contributes to ongoing comfort from associated symptomatic distress and supports indirect protection against disease vectors.


The product is applied in clinical settings that involve acute or unstable symptom patterns caused by external pests, and is commonly used across conditions presenting with acute episodes of infestation. The therapeutic uses include the management of infestations by adult fleas, various species of ticks, and biting lice. Seresto is commonly used as a component of the management strategy for Flea Allergy Dermatitis (FAD), where it contributes to managing the symptoms by eliminating fleas. This provides supportive relief and contributes to improved comfort by easing symptoms related to inflammatory or irritative states.

Furthermore, the product plays a role in managing the reduction of the risk of transmitting certain serious infectious diseases, such as Canine Babesiosis, Ehrlichiosis, and Leishmaniosis, which is relevant across domains where additional symptomatic support is needed.


Quick Fact: Support for Parasite-Related Discomfort
Primary Focus Long-term management of fleas, ticks, and lice.
Symptom Category Symptoms related to inflammatory or irritative states (pruritus, dermatitis).
Context of Use Conditions involving recurrent or episodic manifestations like FAD.
Patient Benefit Supports general well-being by easing the overall symptom load.

Eligibility and Restrictions for Use

Official Eligibility and Restrictions

The eligibility for the Seresto collar is strictly defined by regulatory authorities based on species, age, and health status.

Approved Populations

Species Minimum Age Requirement
Dogs 7 weeks of age and older
Cats 10 weeks of age and older

Absolute Contraindications (Must Not Use)

Use of Seresto is formally contraindicated and must be avoided in specific populations and conditions as stated in regulatory documents:

  • Animals with a known hypersensitivity to the active ingredients (Flumethrin or Imidacloprid) or any of the excipients.
  • Puppies less than 7 weeks of age.
  • Kittens less than 10 weeks of age.

Conditional Use and Precautions

The product label classifies use in certain populations as not recommended because safety has not been established by regulatory bodies:

  • Pregnant and lactating (nursing) animals.
  • Ill or debilitated animals, who should only use the collar after veterinary consultation.

What should I know about interactions with other medicines?

Seresto Interactions with other medicines and products

This section describes the formal interaction profile of Seresto, which contains the active ingredients Imidacloprid and Flumethrin, as documented in government regulatory materials, such as the Summary of Product Characteristics (SPC) issued by national medicines authorities. The official product documentation explicitly addresses the potential for co-administration with other medicinal products and other substances, including those that may affect metabolic or pharmacodynamic pathways.

Category Official Regulatory Finding
Medicinal product categories with documented interactions None known.
Specific interacting medicines None known.
Interaction-related restrictions None known.
Timing-based interaction rules None known.

Official Interaction Status

Regulatory documents consistently state that no known interactions have been established with other medicinal products or other forms of interaction. This formal status means that specific constraints regarding metabolic co-administration, pharmacodynamic effects, or required timing separation are not mandated in the official labeling. Consequently, the regulatory profile does not list any prohibited combinations (contraindications) based on an interaction risk.

Furthermore, no known interactions with food, alcohol, herbal products, or supplements are documented in the official regulatory information. The interaction profile for this product is officially defined by the explicit regulatory declaration of "None known," indicating that authorities have not identified the need for specific co-administration warnings or restrictions.

Mechanism of Action

How Seresto Works: Targeted Neurotoxicity

Seresto utilizes a combination of two active ingredients, imidacloprid and flumethrin, which target distinct elements of the insect and acarine nervous systems. The device's matrix facilitates the continuous, non-systemic release of these compounds onto the animal’s skin and coat lipids. This localized distribution allows the compounds to act via contact on the parasite's neural tissues.

Imidacloprid acts as an agonist at the postsynaptic nicotinic acetylcholine receptors ( nAChRs) in the insect's central nervous system. This binding causes sustained depolarization, resulting in the continuous, uncontrolled excitation of nerve cells. Concurrently, flumethrin modulates the function of voltage-gated sodium channels on the nerve axons. It prolongs the channels’ open state, leading to repetitive, disorganized nerve discharges and a failure of proper repolarization. The combination of these two mechanistic cascades results in hyperexcitation followed by sustained motor dysfunction in the targeted pest species.

Dosage and Administration Information

How Seresto is Used: Official Administration Guidelines

The usage protocol for the Seresto collar is based on a single topical application with specific physical requirements for continuous wear.

Administration Entity Official Label Statement
Route of Administration Cutaneous Use (External / Topical).
Dosing Schedule One collar per animal. Sizing is determined by the species and weight category: 38 cm for cats and small dogs (leq 8 kg), and 70 cm for large dogs (> 8 kg).
Frequency Pattern Single Application designed for continuous, extended wear over the treatment course.
Course Duration The product is designed to be worn continuously for a treatment course lasting seven to eight months, after which it must be removed.
Age-Group Rules Approved for use in kittens aged 10 weeks or older and puppies aged 7 weeks or older.

The official procedure requires removing the collar from its protective pouch immediately before use, unrolling it, and removing any internal plastic connectors. The collar must be fastened around the animal's neck and adjusted to allow a space of approximately two fingers (1 cm to 1.5 cm) between the collar and the neck. Any excess length extending beyond 2 cm should be cut off.

This application process defines a standardized treatment course that is initiated and maintained simply by the proper initial placement of the appropriately sized collar. Although the product is considered water-resistant, prolonged, intensive exposure to water or extensive shampooing may reduce the duration of its activity, which provides a key procedural constraint on its maintenance.

Recent Clinical Evidence

Evidence for Management of Flea Infestations

Research explored the use of this product in infestations caused by fleas, particularly Ctenocephalides felis. The primary research consists of controlled studies, known as Randomized Controlled Trials (RCTs), conducted both in laboratory settings and in field trials. These studies were used in research exploring how symptoms change over time and how the flea population on the animal was observed to change after application. In these trials, the findings describe patterns observed in the studies where measurements indicated low flea counts were present throughout the 8-month tracking periods. Field trials also described patterns of symptom stabilization or reduced skin irritation in animals where Flea Allergy Dermatitis (FAD) was observed.

Evidence for Management of Tick Infestations

The research base examined its use in tick infestations across several RCTs, including controlled laboratory studies using various tick challenges and field studies. The core focus of this research examined measurements of the percentage reduction in the number of live ticks on the animals (an acaricidal endpoint). Studies reported measurements of the anti-tick properties over periods up to 8 months. Data show patterns related to the sustained presence of the active components against new tick infestations. The consistency of these measurements may not fully reflect every diverse natural tick habitat, which means the results reflect the specific conditions under which they were conducted.

Research on Reduction of Vector-Borne Disease Risk

The studies examined outcomes related to the rate of pathogen acquisition by measuring the host's infection rate after exposure to the infected vector. The findings indicate that the rate of pathogen acquisition was studied in comparison to control groups. The measured effect was associated with the control of the vector population (ticks or sand flies). However, findings were mixed regarding the repellent action against certain vectors, such as sand flies, suggesting that the certainty regarding prevention may vary across all geographic regions where the disease is found.

Key Studies & References A new treatment option for fleas and ticks in dogs: imidacloprid and flumethrin delivered via a polymer matrix collar

Frequently Asked Questions (FAQ)

Common questions about Seresto (FAQ)

Q: How long does Seresto protection last?

According to the official product information, the Seresto collar is specified to provide continuous protection against ticks and fleas for up to eight months after it is fitted. Studies and official information indicate that the active ingredients are slowly and continuously released onto the animal’s skin and coat over this time period to help maintain effectiveness.

Q: Can I use Seresto on a puppy or a kitten?

Regulatory documents state that Seresto can be used on puppies and kittens that are 7 weeks of age or older. This is based on specific clinical data for these young animal populations. Information regarding the minimum age and weight requirements is detailed in the official product label.

Q: Is Seresto waterproof, and can my pet swim with it on?

Official product information indicates that the Seresto collar is designed to be water-resistant and maintains its activity if the pet gets wet, for example, from light rain or occasional swimming. However, prolonged and intense exposure to water, such as frequent swimming, is noted in studies as potentially reducing the duration of protection.

Q: How do the active ingredients in Seresto work to kill fleas and ticks?

The Seresto collar releases two active ingredients, imidacloprid and flumethrin. According to regulatory documents, these substances are released in low concentrations and spread across the skin’s surface. They act by targeting the parasites' nervous systems, with the purpose of killing fleas and ticks upon contact as detailed in the regulatory information.

How should Seresto be stored and disposed of?

How to Store and Dispose of Seresto

The storage and disposal of the Seresto collar must comply strictly with official regulatory conditions to ensure product integrity and safety.

Storage Requirements

The collar must be stored in its original container and remain within the original sealed pouch until use. Storage temperature must be maintained at or below 30 C (86 F), and the product must be protected from moisture. As a safety precaution, the collar and the original sealed pouch must be kept out of the sight and reach of children.

Disposal Instructions

Any unused or expired product, including the collar after its period of use, must be disposed of in accordance with local requirements. Due to environmental constraints, the product should not be allowed to enter water courses, as it may pose a hazard to aquatic organisms.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seresto found in:

A-Z Index: